Philip Lowden

Dr. Philip Lowden is a Lecturer at the School of Natural Sciences. His teaching responsibilities include courses such as Drugs and Drug Discovery, Advanced Topics in Human Disease, and Research Skills and Statistics. His research focuses on structural biology, neurodegenerative diseases (particularly Huntington's disease), and microbial biosynthesis. He has contributed to studies on enzyme structures, drug development for neurodegenerative conditions, and antibiotic production pathways.

Dr. Lowden's publications (2003–2012) highlight work on protein crystallography, small molecule drug candidates for cholesterol regulation, and behavioral pharmacology in disease models. His team investigated therapeutic agents like CoQ10, minocycline, and histone deacetylase inhibitors in neurodegenerative contexts. Key projects include precursor-directed biosynthesis of antibiotics such as azinomycins and rapamycin derivatives.

No scientific awards are explicitly listed in the provided materials. His research spans interdisciplinary areas combining biochemistry, microbiology, and translational drug discovery.